CD4 and cancer: Brand and colleagues showed that the production of lactic acid by cancer cells limits CTL and NK cell activation (Figure 1) and impairs IFN-γ production; curiously this pattern was not present in CD4+ and IL-17+ CD4+ (Th17) T cells.